We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
Cap. Flow
-$12.4M
Cap. Flow %
-0.22%
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82

Top Buys

Rank Stock Value
1
ULTA icon
Ulta Beauty
ULTA
+$42M
2
CF icon
CF Industries
CF
+$41.4M
3
BEAV
B/E Aerospace Inc
BEAV
+$36.2M
4
CONE
CyrusOne Inc Common Stock
CONE
+$33.3M
5
SUN icon
Sunoco
SUN
+$29.2M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$55.7M
2
ITC
ITC HOLDINGS CORP
ITC
+$38.9M
3
AGN
Allergan Inc
AGN
+$38.3M
4
ACN icon
Accenture
ACN
+$37.2M
5
TSLA icon
Tesla
TSLA
+$35.7M

Sector Composition

Rank Sector Weight
1 Healthcare 19.43%
2 Financials 16.55%
3 Consumer Discretionary 12.19%
4 Industrials 12.01%
5 Technology 10.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APAM icon
51
Artisan Partners
APAM
$3.09B
$37.3M 0.67%
820,355
-8,740
-1% -$413K
IDXX icon
52
Idexx Laboratories
IDXX
$42.9B
$37.3M 0.67%
482,770
-5,880
-1% -$458K
ARMH
53
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$37M 0.67%
751,287
+498,926
+198% +$24.8M
CONE
54
DELISTED
CyrusOne Inc Common Stock
CONE
$35.1M 0.63%
+1,127,564
New +$33.3M
CAH icon
55
Cardinal Health
CAH
$54.7B
$35.1M 0.63%
388,517
+2,715
+0.7% +$234K
TROW icon
56
T. Rowe Price
TROW
$24B
$35.1M 0.63%
432,906
-6,335
-1% -$522K
AGN
57
DELISTED
Allergan plc
AGN
$34.9M 0.63%
117,102
+75,222
+180% +$21.4M
ETP
58
DELISTED
Energy Transfer Partners, L.P.
ETP
$34.1M 0.62%
825,492
+525,851
+175% +$22.3M
CPAY icon
59
Corpay
CPAY
$26.5B
$34M 0.61%
225,090
-79,597
-26% -$11.8M
EW icon
60
Edwards Lifesciences
EW
$51.8B
$31.5M 0.57%
1,326,672
+1,278,390
+2,648% +$28.7M
BMY icon
61
Bristol-Myers Squibb
BMY
$137B
$30.7M 0.56%
475,920
+443,210
+1,355% +$27.7M
ITC
62
DELISTED
ITC HOLDINGS CORP
ITC
$30.7M 0.55%
819,040
-979,710
-54% -$38.9M
GILD icon
63
Gilead Sciences
GILD
$185B
$29.1M 0.53%
296,506
-158,531
-35% -$16.1M
AMTD
64
DELISTED
TD Ameritrade Holding Corp
AMTD
$29.1M 0.53%
+780,176
New +$27.7M
CVS icon
65
CVS Health
CVS
$119B
$28.1M 0.51%
271,808
-1,612
-0.6% -$163K
BDX icon
66
Becton Dickinson
BDX
$51.2B
$27.9M 0.5%
199,172
+74,509
+60% +$10.4M
UPS icon
67
United Parcel Service
UPS
$89.9B
$27.3M 0.49%
281,903
-272,503
-49% -$28M
POT
68
DELISTED
Potash Corp Of Saskatchewan
POT
$25.2M 0.46%
781,034
-13,781
-2% -$485K
NXPI icon
69
NXP Semiconductors
NXPI
$57B
$25M 0.45%
248,934
+233,592
+1,523% +$20.6M
AMAT icon
70
Applied Materials
AMAT
$383B
$24.6M 0.44%
1,088,668
+5,988
+0.6% +$143K
SHW icon
71
Sherwin-Williams
SHW
$83.8B
$24.4M 0.44%
257,046
-1,842
-0.7% -$172K
BIP icon
72
Brookfield Infrastructure Partners
BIP
$17.9B
$24M 0.43%
1,328,055
+1,082,408
+441% +$18.9M
KSU
73
DELISTED
Kansas City Southern
KSU
$23.8M 0.43%
232,822
-142,156
-38% -$16.1M
CBRE icon
74
CBRE Group
CBRE
$42.6B
$23.3M 0.42%
600,689
-16,712
-3% -$576K
CTSH icon
75
Cognizant
CTSH
$28.7B
$22.8M 0.41%
365,879
+3,662
+1% +$216K
1 2
3
4 5

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.22% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
  • Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
  • Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
  • Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
  • Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
  • Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
  • Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.

Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.